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1158Objective: Posterior pericardiotomy is considered a method to reduce the incidence of atrial fibrillation after car-
diac surgery. Its efficacy in preventing atrial fibrillation and supraventricular arrhythmias after coronary artery
bypass surgery has been evaluated in the present meta-analysis.
Methods: This meta-analysis was performed in accordance with the Cochrane Handbook for Systematic
Reviews.
Results: The search yielded 6 prospective, randomized studies reporting on postoperative atrial fibrillation in 763
patients after coronary artery bypass grafting. The cumulative incidence of atrial fibrillation was 10.8% in the
posterior pericardiotomy group (PP group) and 28.1% in the control group (I2 68%, random effect: P ¼ .003;
odds ratio [OR], 0.33; 95% confidence interval [CI], 0.16–0.69). Supraventricular arrhythmias occurred in
13.8% of patients in the PP group and 35.4% in the control group (I2 70%, random effect: P ¼ .002; OR,
0.31; 95% CI, 0.15–0.65). Early pericardial effusion (6.9% vs 46.2%; I2 67%; random effect: P< .0001;
OR, 0.10; 95% CI, 0.04–0.28) and late pericardial effusion (0% vs 11.3%; I2 0%; fixed effect: P ¼ .0001;
OR, 0.04; 95% CI, 0.01–0.21) were significantly less frequent in the PP group. Pleural effusion (5 studies in-
cluded: 22.2% vs 17.1%; I2 0%; fixed effect: P ¼ .10; OR, 1.40; 95% CI, 0.94–2.08) and pulmonary compli-
cations were only slightly more frequent in the PP group (4 studies included: 3.6% vs 2.5%; I2 0%; fixed effect:
P ¼ .46; OR, 1.45; 95% CI, 0.54–3.86).
Conclusions: Posterior pericardiotomy seems to significantly reduce the incidence of postoperative atrial fibril-
lation and supraventricular arrhythmias after coronary artery bypass grafting. The marked reduction of postoper-
ative pericardial effusion after posterior pericardiotomy suggests that pericardial effusion is one of the main
triggers involved in the development of atrial fibrillation after cardiac surgery. (J Thorac Cardiovasc Surg
2010;139:1158-61)Atrial fibrillation (AF) is the most common complication
occurring after cardiac surgery and is associated with hemo-
dynamic instability, prolonged hospital stay, stroke, and in-
creased costs.1,2 AF is also one of the main causes of hospital
readmission.3 Pathogenesis of AF after cardiac surgery is
multifactorial, and mechanisms are still largely unknown.
Increase in circulating catecholamines, heightened sympa-
thetic and parasympathetic tone, atrial stretch, transcellular
fluid and electrolyte shifts, metabolic abnormalities, inflam-
mation, and pericarditis are believed to be the most impor-
tant factors contributing to AF after cardiac surgery.4
A significant number of trials have been performed show-
ing the efficacy of several drugs in preventing postoperative
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ciated with marked incremental costs.
Posterior pericardiotomy (PP) is considered amethod to re-
duce the risk of AF inasmuch as it allows drainage of pericar-
dial blood/effusion into the left pleural space, reducing the
incidence of pericardial effusion, which may trigger AF.6
The present meta-analysis was carried out to evaluate the effi-
cacy of this method in preventing postoperative AF and other
supraventricular arrhythmias, as well as pericardial effusion.MATERIAL AND METHODS
This meta-analysis of randomized trials was performed in accordance
with the Cochrane Handbook for Systematic Reviews.7 Reference search
was performed through PubMed and Cochrane Library up to February
2009 for trials evaluating the efficacy of PP in preventing AF after cardiac
surgery. The following words were used in the search: posterior pericardiot-
omy, pericardial fenestration, and pericardial window. Handbooks as well
as cardiology and cardiac surgery journals have been searched as well.
Only prospective, randomized studies with allocation to PP or control in
adult patients undergoing any type of cardiac surgery and reporting at least
on postoperative AFwere included in the present analysis. Clinical variables
and outcome end points were reported as originally defined by the authors.
The primary outcome end points of this study are AF and supraventric-
ular arrhythmias. Secondary outcome end points are pericardial effusion,
pleural effusion, and pulmonary complications.gery c May 2010
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rdiopulmonatrial fibrillationCABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
OR ¼ odds ratio
PP ¼ posterior pericardiotomy
RR ¼ risk ratioData Collection and Analysis
Both authors independently abstracted data from all eligible studies us-
ing a standardized Excel file. We retrieved data on study design, study size,
patient demographics, type of surgery, intraoperative data, and any outcome
end points.
The risk of bias has been assessed independently by both of us according
to the Cochrane Collaboration criteria for assessing risk of bias.7 Disagree-
ment has been resolved by consensus. Trials that met eligibility criteria have
been assessed for generation of random allocation sequence, allocation con-
cealment, blinding of intervention, incomplete outcome data, freedom of
selective reporting, and freedom from other biases. Missing data have
been evaluated and a dropout rate of less than 5% has been considered as
acceptable.
Meta-analysis was performed using Review Manager 5.0.18 (Copenha-
gen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008).
Outcome end points were expressed as odds ratio (OR) and risk ratio
(RR) with 95% confidence interval (CI). Continuous variables were re-
ported as weighted mean differences and 95% CI. Heterogeneity has
been assessed by using I2 and c2 test. I2 less than 40% has been considered
as nonimportant heterogeneity. In case of important heterogeneity, we have
used the random-effects model. The small number of studies included in this
meta-analysis, as well as the paucity of clinical and operative variables re-
ported in the studies, prevented meta-regression analysis.
RESULTS
The search yielded 9 articles that were pertinent with this
issue. Two of them were excluded because they were case
reports. Another article, a prospective randomized study
on the efficacy of PP in heart valve surgery, was excluded
because no data on the incidence of postoperative AF were
reported.8 Data on postoperative AF that occurred in the
third trial were requested from the authors, but they were
not able to provide any information on this outcome end
point. Thus, 6 prospective, randomized studies reporting
on postoperative AF after conventional coronary artery by-ary of studies included in the meta-analysis
No. of patients Patien
Type of surgery Control PP Control
CABG 50 50 60.1  3.2
al9 CABG 50 50 60.1  9.0
CABG 100 100 62.8  5.4
CABG 75 75 61  8
CABG 59 54 61  2
CABG 50 50 62.5  4.9
ry bypass; PP, posterior pericardiotomy; CABG, coronary artery byp
The Journal of Thoracic and Carpass surgery (CABG) have been included in the present
meta-analysis.6,9-13
In all, 763 patients were evaluated in these 6 studies, 389
patients in the PP groups and 374 in the control groups. PP
was performed in all studies as a longitudinal incision paral-
lel and posterior to the phrenic nerve, extending from the left
inferior pulmonary vein to the diaphragm according to the
technique described by Mulay and colleagues.6 One drain
was inserted into the left pleural cavity and another into
the anterior mediastinum.
Patients were monitored for arrhythmias during the in-
hospital stay. Continuous electrocardiographic monitoring
was performed during the first 48 to 96 postoperative hours
and then daily or as required.6,9-13
Regarding the methodologic quality of the studies, only
2 of them reported on adequate sequence generation, all
studies were free of selective reporting and other biases,
and information about allocation concealment, blinding,
and incomplete outcome data were not reported in any
of them.
No difference in terms of patients’ ages (I2 56%; random
effect: P ¼ .70; mean difference0.30; 95% CI,1.36 to
0.77), aortic crossclamping time (I2 80%; random effect:
P ¼ .71; mean difference0.84; 95% CI,5.22 to 3.55),
and cardiopulmonary bypass duration (I2 51%; random
effect: P ¼ .30; mean difference1.36; 95% CI,3.91 to
1.19) were observed between the study groups (Table 1).
Drainage blood loss was somewhat lower in the control
group (I2 87%; random effect: P ¼ .41; mean difference
24.38; 95% CI, 33.89 to 82.64), but the difference was
not statistically significant.
Not enough data were available for analysis of postoper-
ative mortality and reoperation.
The cumulative incidence of AF was 10.8% in the PP
group and 28.1% in the control group (I2 68%; random ef-
fect: P ¼ .003; OR, 0.33; 95% CI, 0.16–0.69; RR, 0.41;
95% CI, 0.22–0.76) (Figure 1, A).
The cumulative incidence of supraventricular arrhyth-
mias was 13.8% in the PP group and 35.4% in the
control group (I2 70%; random effect: P ¼ .002; OR,
0.31; 95% CI, 0.15–0.65; RR, 0.41; 95% CI, 0.23–
0.74) (Figure 1, B).ts’ age (y)
Aortic crossclamping
time (min) CPB duration (min)
PP Control PP Control PP
59.1  8.9 43  6 46  20 85  4 90  33
62.3  8.2 33  8 35  2 62  17 66  17
64.2  8.9 43  9 36  12 51  4 48  5
57  12 40  9 35  11 61  9 57  6
61  9 60  19 58  17 112  35 117  32
62  7 62  12 63  19 87  26 89  21
ass grafting. Continuous variables are reported as the mean  standard deviation.
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Study or Subgroup
Mulay 1995
Asimakopoulos 1997
Kuralay 1999
Farsak 2002
Arbatli 2003
Ekim 2006
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.57; Chi² = 15.78, df = 5 (P = 0.008); I² = 68%
Test for overall effect: Z = 2.94 (P = 0.003)
Events
4
12
6
7
7
5
41
Total
50
50
100
75
54
50
379
Events
14
9
34
24
12
15
108
Total
50
50
100
75
59
50
384
Weight
14.9%
17.2%
17.7%
17.8%
16.7%
15.8%
100.0%
M-H, Random, 95% CI
0.22 [0.07, 0.74]
1.44 [0.55, 3.80]
0.12 [0.05, 0.31]
0.22 [0.09, 0.55]
0.58 [0.21, 1.61]
0.26 [0.09, 0.78]
0.33 [0.16, 0.69]
Year
1995
1997
1999
2002
2003
2006
Experimental Control Odds Ratio
Odds Ratio
Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Study or Subgroup
Mulay 1995
Asimakopoulos 1997
Kuralay 1999
Farsak 2002
Ekim 2006
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.51; Chi² = 13.44, df = 4 (P = 0.009); I² = 70%
Test for overall effect: Z = 3.07 (P = 0.002)
Events
4
13
11
10
7
45
Total
50
50
100
75
50
325
Events
18
10
40
28
19
115
Total
50
50
100
75
50
325
Weight
16.9%
19.9%
22.5%
21.5%
19.3%
100.0%
M-H, Random, 95% CI
0.15 [0.05, 0.50]
1.41 [0.55, 3.59]
0.19 [0.09, 0.39]
0.26 [0.11, 0.58]
0.27 [0.10, 0.71]
0.31 [0.15, 0.65]
Year
1995
1997
1999
2002
2006
Experimental Control Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
FIGURE 1. Forest plots of comparison between posterior pericardiotomy (experimental) group and control group for prevention of postoperative (A) atrial
fibrillation and (B) supraventricular arrhythmias after coronary artery bypass surgery. CI, Confidence interval; M-H, Mantzel-Haenzel method.
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DEarly pericardial effusion (4 studies included: 6.9% vs
46.2%; I2 67%; random effect: P < .0001; OR, 0.10;
95% CI, 0.04–0.28; RR, 0.17; 95% CI, 0.07–0.42) as
well as late pericardial effusion (4 studies included: 0% vs
11.3%; I2 0%; fixed effect: P ¼ .0001; OR, 0.04; 95%
CI, 0.01–0.21; RR, 0.05; 95% CI, 0.01–0.24) were signifi-
cantly less frequent in the PP group.
Pleural effusion (5 studies included: 22.2% vs 17.1%;
I2 0%; fixed effect: P ¼ .10; OR, 1.40; 95% CI, 0.94–
2.08; RR, 1.29; 95% CI, 0.95–1.74) and pulmonary com-
plications were only slightly more frequent in the PP
group (4 studies included: 3.6% vs 2.5%; I2 0%; fixed ef-
fect: P ¼ .46; OR, 1.45; 95% CI, 0.54–3.86; RR, 1.43;
95% CI, 0.55–3.69).
DISCUSSION
The results of this meta-analysis indicate that PP mark-
edly reduces the incidence of AF and supraventricular ar-
rhythmias after CABG. The OR of PP (OR, 0.31) in
preventing postoperative AF is even better than that with
the use of beta-blockers, sotalol, corticosteroids, and amio-1160 The Journal of Thoracic and Cardiovascular Surdarone as estimated in previous meta-analyses (OR ranging
from 0.36 to 0.48).1,5
The antiarrhythmic effect of PP was associated with
a significant reduction in the incidence of early and late peri-
cardial effusion. It is likely that the reduced risk of AF after
PP is due to decreased pericardial effusion, which may trig-
ger postoperative supraventricular arrhythmias. The mecha-
nisms by which pericardial effusion may lead to these
arrhythmias are not clear. We can just speculate that a certain
amount of fluid/hematoma into the pericardium may repre-
sent a mechanical stimulus to the atria, whose function can
be affected by external compression.
The slightly increased blood loss in the PP group suggests
that this method provides an effective pathway of drainage
to the pleural cavity of pericardial blood/effusion, which
otherwise would have been collected in the pericardium
and compressed the heart. Importantly, pleural effusion
and pulmonary complications were not significantly more
frequent in the PP group.
These results are not conclusive inasmuch as further
studies with better methodology are needed. In fact, thegery c May 2010
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optimal. The method of randomization was reported in only
2 studies and information regarding allocation concealment,
blinding, and incomplete outcome data were not reported.
Importantly, there are no data regarding the use of drugs
for AF prophylaxis, which represents a major bias for correct
interpretation of these data. Other major pitfalls are the lack
of data on postoperative hemodynamic instability, reopera-
tion for bleeding/pericardial effusion, and potential AF-
related complications such as stroke, renal failure, prolonged
length of in-hospital stay, and readmission.
PP is easy to do and it is cost-free. However, it is not free
of complications. Besides the potential risk of cardiac herni-
ation, bypass grafts after CABG can protrude through and be
squeezed by the edges of the PP.14 These complications are
likely to be minimized by performing a limited PP at the end
of the procedure at a distance from the bypass grafts. How-
ever, the risk of such PP-related complications also deserves
further evaluation.
In conclusion, this meta-analysis suggests that adding PP
during CABG seems to reduce the incidence of postopera-
tive AF and supraventricular arrhythmias. The marked re-
duction of postoperative pericardial effusion observed after
PP suggests that the former is one of the main triggers of
AF occurring after cardiac surgery.
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